Jennifer Godshall
Adult Health · Tampa, FLNPI 1568789287
Payments from drug & device makers
Across 503 payments — averaging $58.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$22K
- Johnson & Johnson$2K
- Sanofi$606
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$538
- QOL Medical, LLC$496
- Takeda Pharmaceuticals U.S.A., Inc.$415
- plus $3K from 27 others
What the payments were for
- Consulting fees$1,3505%
- Speaking & faculty fees$11,60040%
- Travel & lodging$3,91713%
- Food & beverage$12,26542%
- Education$2331%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 249 | $21,525 |
| Johnson & Johnson | 29 | $2,419 |
| Sanofi | 26 | $606 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 44 | $538 |
| QOL Medical, LLC | 18 | $496 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $415 |
| Pfizer | 26 | $388 |
| Lilly USA, LLC | 8 | $388 |
| Janssen Scientific Affairs, LLC | 3 | $362 |
| Gilead | 12 | $314 |
| Bristol Myers Squibb | 12 | $232 |
| Ferring Pharmaceuticals Inc. | 4 | $223 |
| Celltrion USA Inc. | 6 | $179 |
| Phathom Pharmaceuticals, Inc. | 4 | $174 |
| Nestle Healthcare Nutrition Inc. | 4 | $167 |
| Ardelyx, Inc. | 6 | $133 |
| Regeneron Healthcare Solutions, Inc. | 5 | $131 |
| Novo Nordisk | 1 | $122 |
| Madrigal Pharmaceuticals | 3 | $98 |
| Vivus LLC | 5 | $94 |
| Boehringer Ingelheim | 4 | $78 |
| Redhill Biopharma Inc. | 3 | $58 |
| Ipsen Biopharmaceuticals, Inc | 2 | $54 |
| Coloplast | 1 | $23 |
| Lumendi LLC | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Medtronic | 1 | $19 |
| Lucid Diagnostics Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Amgen | 1 | $13 |
| Evoke Pharma, Inc. | 1 | $13 |
| Organon | 1 | $12 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,365 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 58 | $252,087 |
| Humira(Cf) PenAdalimumab | 14 | $187,460 |
| ZenpepLipase/Protease/Amylase | 29 | $149,421 |
| LinzessLinaclotide | 13 | $17,002 |
| TrulancePlecanatide | 15 | $8,947 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 31 | $5,418 |
| Omeprazole | 79 | $1,731 |
| Famotidine | 53 | $1,220 |
| Pantoprazole Sodium | 79 | $903 |
| Dicyclomine Hcl | 24 | $622 |
| Ondansetron Hcl | 17 | $262 |
| Hydroxyzine Hcl | 15 | $231 |
| Metronidazole | 13 | $145 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $21,525 | $269,08971 claims |
| Aimmune Therapeutics, Inc.Zenpep | $21 | $149,42129 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $538 | $8,94715 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $223 | $5,41831 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,237 adult health providers in Florida.
Other adult health in Tampa
- Jamie JohnsonTampa$58K
- Michael RoggelinTampa$21K
- Mercedes FernandezTampa$19K
- Cashawna SchlossnagleTampa$18K
- Jennifer BishopTampa$17K
- Meredith ButlerTampa$16K
- Kimberly RandolphTampa$14K
- Esmeralda YoungTampa$14K
- Peggy WallaceTampa$12K
- Sarah KossiverTampa$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.